retatrutide phase 3 trials 3: TRIUMPH Program Results 2026 Eli Lilly retatrutide Phase 3

Subjective and objective markers for plateau include diminishing benefits after initial improvements, requiring higher doses for same effects, increased side effects relative to benefits, and biomarkers stopping improvement despite continued use

Medical evaluation is appropriate when sulfur burps or bloating on GLP-1 medications are severe, persistent, or worsening , particularly if symptoms interfere with nutrition, hydration, or daily functioning

Campbell in Nutrition Reviews shows that calorie restriction can lead to reductions in lean body mass unless sufficient protein intake and resistance training are maintained

[DOI] [PMC free article] [PubMed] [Google Scholar] 86.Liu G, et al

Paraquat, a widely-used herbicide, has been linked to Parkinsons disease, leading to numerous Paraquat Parkinsons Disease Lawsuits against its manufacturers for failing to warn about the risks of chronic exposure